Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

HOW WE DO IT

Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we build functional pre-clinical in vitro models of kidney, retina, liver and lung. We engineer them from patient samples and a range of pre-clinical species.

Don't miss out on our latest innovations: follow us on Linkedin

Published

24th April, 2019

Categories

Update

Get our latest updates straight to your inbox